• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     NIHR Health Technology Assessment programme Ranibizumab for the treatment of choroidal neovascularisation associated with pathological myopia
2013     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for the treatment of aortic valve stenosis: an evidence update
2013     NIHR Horizon Scanning Centre (NIHR HSC) Prolonged release naltrexone and bupropion (Contrave) for the management of obesity
2013     NIHR Health Services and Delivery Research programme Towards equitable commissioning for our multiethnic society: a mixed-methods qualitative investigation of evidence utilisation by strategic commissioners and public health managers
2013     NIHR Horizon Scanning Centre (NIHR HSC) Parachute® Implant System for ischaemic heart failure
2013     NIHR Health Technology Assessment programme Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2 positive metastatic or locally recurrent unresectable breast cancer: a single technology appraisal
2013     Health Quality Ontario (HQO) OHTAC recommendation: transcatheter aortic valve implantation for treatment of aortic valve stenosis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Anamorelin for anorexia-cachexia in advanced non-small cell lung cancer
2013     NIHR Health Services and Delivery Research programme An evaluation of foundation doctor training: a mixed-methods study of the impact on workforce well-being and patient care [the Evaluating the Impact of Doctors in Training (EDiT) study]
2013     Medical Services Advisory Committee (MSAC) Capsule endoscopy for the diagnosis of suspected small bowel Crohn disease
2013     NIHR Health Technology Assessment programme Screening for type 2 diabetes: a short report for the National Screening Committee
2013     NIHR Horizon Scanning Centre (NIHR HSC) T30 neurostimulator device for chronic tonal subjective tinnitus
2013     NIHR Health Technology Assessment programme Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
2013     Health Quality Ontario (HQO) Photoselective vaporization for the treatment of benign prostatic hyperplasia
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ezetimibe (Ezetrol) in combination with a statin for reduction of cardiovascular risk in coronary heart disease
2013     University of York Patient safety. 10 things NHS Trusts should already be doing
2013     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation
2013     NIHR Health Technology Assessment programme Lenalidomide for the treatment of myelodysplastic syndromes associated with deletion 5q cytogenetic abnormality
2013     Health Quality Ontario (HQO) OHTAC recommendation: photoselective vaporization for the treatment of benign prostatic hyperplasia
2013     NIHR Health Technology Assessment programme Rapid fetal fibronectin (fFN) testing to predict pre-term birth in women with symptoms of premature labour: A systematic review and cost-effectiveness analysis
2013     NIHR Health Technology Assessment programme Aflibercept solution for injection for the treatment of wet age-related macular degeneration
2013     Health Quality Ontario (HQO) Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework
2013     NIHR Health Technology Assessment programme Pirfenidone for the treatment of idiopathic pulmonary fibrosis
2013     NIHR Health Technology Assessment programme Pragmatic cluster randomised trial of PhysioDirect telephone assessment and advice services for physiotherapy
2013     NIHR Health Technology Assessment programme Aflibercept in combination with irinotecan and fluorouracil-based therapy for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy
2013     Health Quality Ontario (HQO) OHTAC recommendation: optimizing chronic disease management in the community (outpatient) setting (OCDM)
2013     Scottish Health Technologies Group (SHTG) Is patient self-monitoring (including self-testing and self-management) of oral anticoagulation therapy safe, efficacious and cost-effective?
2013     Health Quality Ontario (HQO) Discharge planning in chronic conditions: an evidence-based analysis
2013     Institute for Clinical Evaluative Sciences (ICES) Ontario stroke evaluation report 2013: spotlight on secondary stroke prevention and care
2013     Health Quality Ontario (HQO) In-home care for optimizing chronic disease management in the community: an evidence-based analysis
2013     Institute for Clinical Evaluative Sciences (ICES) Atlas on the primary care of adults with developmental disabilities in Ontario
2013     Health Quality Ontario (HQO) Continuity of care to optimize chronic disease management in the community setting: an evidence-based analysis
2013     Health Quality Ontario (HQO) Impact of advanced (open) access scheduling on patients with chronic diseases: an evidence-based analysis
2013     The Regional Health Technology Assessment Centre (HTA-centrum) Renal sympathetic denervation in patients with therapy resistant hypertension
2013     Health Quality Ontario (HQO) Screening and management of depression for adults with chronic diseases: an evidence-based analysis
2013     Health Quality Ontario (HQO) Self-management support interventions for persons with chronic disease: an evidence-based analysis
2013     Health Quality Ontario (HQO) Specialized nursing practice for chronic disease management in the primary-care setting: an evidence-based analysis
2013     NIHR Health Technology Assessment programme Ivabradine for the treatment of chronic heart failure
2013     Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of surveillance of women aged less than 50 years at elevated risk of breast cancer
2013     Health Quality Ontario (HQO) Electronic tools for health information exchange: an evidence-based analysis
2013     NIHR Health Technology Assessment programme Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema
2013     Health Quality Ontario (HQO) Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011
2013     Medical Advisory Secretariat (MAS) Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2013     Health Quality Ontario (HQO) Optimizing chronic disease management mega-analysis: economic evaluation
2013     Health Quality Ontario (HQO) How diet challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Chronic disease patients' experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis
2013     Agenzia nazionale per i servizi sanitari regionali (Agenas) Selective Internal Radiation Therapy (SIRT) in colorectal liver metastases
2013     Health Quality Ontario (HQO) Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis
2013     Health Quality Ontario (HQO) Electrical stimulation for drug-resistant epilepsy: OHTAC recommendation
2013     Health Quality Ontario (HQO) Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: an evidence-based analysis
2013     Health Quality Ontario (HQO) Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: OHTAC recommendation
2013     Health Technology and Policy Unit (HTPU) Level I and level III sleep studies for the diagnosis of sleep disordered breathing (SDB) in adults
2013     Health Quality Ontario (HQO) Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis
2013     Medical Services Advisory Committee (MSAC) Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: an evidence-based analysis
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: OHTAC recommendation
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: a health economic literature review
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: an evidence-based analysis
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: OHTAC recommendation
2013     Health Quality Ontario (HQO) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2013     HAYES, Inc. SensiGene fetal RHD genotyping
2013     University of York Inpatient rehabilitation services for the frail elderly
2013     Agency for Healthcare Research and Quality (AHRQ) Pulmonary arterial hypertension: screening, management, and treatment
2013     Health Quality Ontario (HQO) Deep brain stimulation for treatment-resistant depression: a preliminary evidence review
2013     University of York Evidence briefing on non-pharmacological interventions for dementia in care home settings
2013     Institute for Clinical and Economic Review (ICER) Cardiac nuclear imaging
2013     Health Quality Ontario (HQO) OHTAC recommendation: deep brain stimulation for treatment-resistant depression
2013     University of York Telehealth for patients with long term conditions
2013     Institute for Clinical and Economic Review (ICER) Cervical spinal fusion for degenerative disc disease
2013     Health Quality Ontario (HQO) OHTAC recommendation: endovascular ablation for varicose veins
2013     NIHR Horizon Scanning Centre (NIHR HSC) The SurroSense Rx™ System for prevention of diabetic foot ulcers
2013     University of York Evidence briefing on urgent care systems
2013     Health Quality Ontario (HQO) Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013     NIHR Horizon Scanning Centre (NIHR HSC) ATI™ Neurostimulation System for cluster headache
2013     University of York Consolidating urgent care services
2013     Health Quality Ontario (HQO) OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ellex 2RT™ for early age-related macular degeneration
2013     University of York Advance care planning
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) OssDsign™ Cranio PSI for skull repair
2013     University of York Primary care 'in-reach' in hospital settings
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013     NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013     Medical Services Advisory Committee (MSAC) Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013     NIHR Horizon Scanning Centre (NIHR HSC) Smart-Glasses depth-based visual aids for the partially sighted
2013     Medical Services Advisory Committee (MSAC) Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Full Sense™ device for obesity
2013     Medical Services Advisory Committee (MSAC) Transcatheter closure of patent ductus arteriosus
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013     Medical Services Advisory Committee (MSAC) Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Mini C-arm imagers for the follow-up of orthopedic patients: clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Dressings and care of skin graft sites: a review of clinical evidence and guidelines
2013     Medical Services Advisory Committee (MSAC) Matrix-induced autologous chondrocyte implant
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2013     Medical Services Advisory Committee (MSAC) Sexual health medicine consultation items
2013     Adelaide Health Technology Assessment (AHTA) Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder